Title : Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia.

Pub. Date : 2019 Dec

PMID : 31074316






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The MTD was DL3: lenalidomide 5 mg daily D8-21 of C1, then 10 mg D1-21 of C2-6. Lenalidomide metallothionein 1E Homo sapiens